Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | Dosing
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Dosing
Anvari K, Seilanian Toussi M, Saghafi M, Javadinia SA, Saghafi H,
Welsh JS.
Extended dosing (12 cycles)
vs conventional dosing (6 cycles) of adjuvant temozolomide in
adults with newly diagnosed high-grade gliomas: a randomized,
single-blind, two-arm, parallel-group controlled trial.
Front
Oncol. 2024 May 7;14:1357789. doi:
10.3389/fonc.2024.1357789. PMID:
38774410. Interventional
study. ˍ
Fasano
M, Pirozzi M, De Falco V, Miceli CC, Farese S, Zotta A,
Famiglietti V, Vitale P, Di Giovanni I, Brancati C, Carfora V,
Solari D, Somma T, Cavallo LM, Cappabianca P, Conson M, Pacelli R,
Ciardiello F, Addeo R.
Temozolomide
based treatment in glioblastoma: 6 vs. 12 months.
Oncol
Lett. 2024 Jul 2;28(3):418. doi:
10.3892/ol.2024.14551. PMID:
39006948. Observational study. ˍ